Angion Biomedica Total Assets 2020-2021 | ANGN

Angion Biomedica total assets from 2020 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Angion Biomedica Annual Total Assets
(Millions of US $)
2020 $47
2019 $12
Angion Biomedica Quarterly Total Assets
(Millions of US $)
2021-09-30 $110
2021-06-30 $125
2021-03-31 $139
2020-12-31 $47
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $12
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.070B $0.003B
Angion Biomedica Corp. is a late-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Angion Biomedica Corp. is based in UNIONDALE, N.Y.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69